[Comparison of the effectiveness and safety of glaucoma drugs in the therapy of primary open-angle glaucoma].
S Yu AstakhovP A NechiporenkoD P NovikovO A FrolovA S PokrovskiyPublished in: Vestnik oftalmologii (2024)
The results of this study allow a conclusion that the effectiveness and safety of Trilaktan (Groteks, Russia) eye drops are equal to those of Xalatan (Pfizer MFG. Belgium N.V., Belgium) eye drops in patients with POAG of early and moderate stages or OH. Trilaktan is easy to use thanks to the included eye drops dispenser.